TY  - GEN
AU  - Moreau,Philippe
AU  - Karamanesht,Ievgenii I
AU  - Domnikova,Natalia
AU  - Kyselyova,Maryna Y
AU  - Vilchevska,Kateryna V
AU  - Doronin,Vadim A
AU  - Schmidt,Alexander
AU  - Hulin,Cyrille
AU  - Leleu,Xavier
AU  - Esseltine,Dixie-Lee
AU  - Venkatakrishnan,Karthik
AU  - Skee,Donna
AU  - Feng,Huaibao
AU  - Girgis,Suzette
AU  - Cakana,Andrew
AU  - van de Velde,Helgi
AU  - Deraedt,William
AU  - Facon,Thierry
TI  - Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma
SN  - 1179-1926
PY  - 2013///0418
KW  - Administration, Intravenous
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Area Under Curve
KW  - Boronic Acids
KW  - Bortezomib
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - blood
KW  - Proteasome Endopeptidase Complex
KW  - Pyrazines
KW  - Recurrence
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s40262-012-0010-0
ER  -